Lack of association with interleukin 1 receptor antagonist and interleukin-1 β gene polymorphisms in sarcoidosis patients
✍ Scribed by T. NIIMI; S. SATO; H. TOMITA; Y. YAMADA; K. AKITA; H. MAEDA; H. KAWAGUCHI; Y. SUGIURA; R. UEDA
- Book ID
- 117829368
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 161 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0954-6111
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Cytokines play key roles in immune responses, inflammation and fibrosis. The balance between levels of cytokines, their receptors and specific inhibitors controls inflammatory reactions in tissues. The pathogenesis of lichen sclerosus is unknown but probably involves cytokine mediators such as inter
## Objective: To test if interleukin-1beta (il-1beta), il-1 receptor antagonist (il-1ra), il-4, or il-10 gene polymorphisms could be used as markers of susceptibility or severity in rheumatoid arthritis (ra). ## Methods: The study included 108 patients with early ra followed up for 2 years and 12
## Abstract Interleukin‐1 (IL‐1) is considered to be involved in the pathogenesis of Graves' disease. The aim of this study was to test whether the IL‐1‐β gene promoter region and exon 5 and IL‐1 receptor antagonist (IL‐1Ra) gene intron 2 polymorphisms could be useful genetic markers for susceptibi